The Impact on Survival of Neoadjuvant Treatment Interruptions in Locally Advanced Rectal Cancer Patients

The Impact on Survival of Neoadjuvant Treatment Interruptions in Locally Advanced Rectal Cancer Patients

The standard oncologic treatment of locally advanced rectal cancer is long-course radio-chemotherapy followed by surgery and adjuvant chemotherapy. This can result in a lengthy total treatment duration, sometimes up to one year from the diagnosis. Interruptions to neoadjuvant treatment can occur for...

Full description

Bibliographic Details
Main Authors:	Horia-Dan Lișcu, Ionut-Lucian Antone-Iordache, Dimitrie-Ionuț Atasiei, Ioana Valentina Anghel, Andreea-Teodora Ilie, Taraneh Emamgholivand, Andreea-Iuliana Ionescu, Florica Șandru, Christopher Pavel, Flavia Ultimescu
Format:	Article
Language:	English
Published:	MDPI AG 2024-02-01
Series:	Journal of Personalized Medicine
Subjects:	neoadjuvant radiotherapy total neoadjuvant treatment locally advanced rectal cancer downstage treatment interruptions
Online Access:	https://www.mdpi.com/2075-4426/14/3/266

Similar Items

The Conditioning of Adjuvant Chemotherapy for Stage II and III Rectal Cancer Determined by Postoperative Pathological Characteristics in Romania
by: Horia-Dan Liscu, et al.
Published: (2023-06-01)

The value of restaging CT following neoadjuvant chemotherapy for resectable gastric cancer. A population-based study
by: Alina Desiree Sandø, et al.
Published: (2021-07-01)

Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival?
by: Violette Fossaert, et al.
Published: (2022-10-01)

Prediction of Subclinical and Clinical Multiple Organ Failure Dysfunction in Breast Cancer Patients—A Review Using AI Tools
by: Andreea-Iuliana Ionescu (Miron), et al.
Published: (2024-01-01)

Assessing the Impact of Organ Failure and Metastases on Quality of Life in Breast Cancer Patients: A Prospective Study Based on Utilizing EORTC QLQ-C30 and EORTC QLQ-BR45 Questionnaires in Romania
by: Andreea-Iuliana Ionescu (Miron), et al.
Published: (2024-02-01)

Changes in Oncological Surgical Principles Driven by Advances in Preoperative Treatments
by: Horváth ÖP, et al.
Published: (2023-08-01)

Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study
by: Christina Tanem Møller, et al.
Published: (2022-12-01)

Hepatosellüler karsinomada bridging veya downstaging sonrası karaciğer transplantasyonu ile direkt transplantasyon stratejilerinin sağkalım üzerine etkilerinin karşılaştırılması
by: Tuğsan Ballı, et al.
Published: (2019-12-01)

Consolidation chemotherapy may improve pathological complete response for locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a retrospective study
by: Jin Cui, et al.
Published: (2020-07-01)

Neoadjuvant Systemic Treatment of Primary Angiosarcoma
by: Kimberley M. Heinhuis, et al.
Published: (2020-08-01)

Neoadjuvant Chemoradiotherapy versus Chemotherapy for Gastroesophageal Junction Adenocarcinoma; Which Is the Optimal Treatment Option?
by: Eric Zandirad, et al.
Published: (2022-11-01)

Does neoadjuvant rectal score predict treatment outcomes better than the all grading systems used in neoadjuvantly treated rectal cancer?
by: Fatma Sert, et al.
Published: (2023-10-01)

Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition)
by: Expert group of expert consensus on neoadjuvant treatment of breast cancer in China ( edition)
Published: (2022-01-01)

MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study
by: Yirong Xiang, et al.
Published: (2023-01-01)

Neoadjuvant systemic therapy for patients with gastric cancer: Current concepts and outcomes
by: Fatih Selcukbiricik, et al.
Published: (2016-01-01)

Initial results of treatment of rectal cancer using the neoadjuvant treatment
by: Marić Zdravko, et al.
Published: (2014-01-01)

Radical therapy of resectable and borderline resectable pancreatic cancer – present state of knowledge. Do we have sufficient data to use neoadjuvant treatment?
by: Robert Dziura, et al.
Published: (2020-06-01)

Radiotherapy in the preoperative neoadjuvant treatment of locally advanced rectal cancer
by: Zhen Yu, et al.
Published: (2023-11-01)

Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery
by: Xiang-Bo Wan, et al.
Published: (2020-08-01)

Neoadjuvant Treatment Options in Soft Tissue Sarcomas
by: Mateusz Jacek Spałek, et al.
Published: (2020-07-01)

Determinants of treatment interruption and outcome among smear-positive pulmonary tuberculosis patients in a tuberculosis unit of Purba Bardhaman district of West Bengal
by: Chinmay Nandi, et al.
Published: (2022-01-01)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
by: Dubrocq G, et al.
Published: (2018-06-01)

Challenges and shifting treatment strategies in the surgical treatment of locally advanced rectal cancer
by: Ho Seung Kim, et al.
Published: (2020-07-01)

Surgical perspective in neoadjuvant chemoimmunotherapy for stage II–III non‐small cell lung cancer
by: Tao Hong, et al.
Published: (2021-10-01)

Long-Term Outcome of Patients with Stage II and III Muscle-Invasive Urothelial Bladder Cancer after Multimodality Approach. Which Is the Best Option?
by: Oana Gabriela Trifanescu, et al.
Published: (2022-12-01)

Metabolic Signatures: Pioneering the Frontier of Rectal Cancer Diagnosis and Response to Neoadjuvant Treatment with Biomarkers—A Systematic Review
by: Răzvan Alexandru Ciocan, et al.
Published: (2024-02-01)

Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot study
by: Guanglei Chen, et al.
Published: (2023-12-01)

Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Factors—Literature Review
by: Aiste Gulla, et al.
Published: (2022-06-01)

Post-Neoadjuvant Treatment Strategies in Breast Cancer
by: Christiane Matuschek, et al.
Published: (2022-02-01)

Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions
by: Angelica Petrillo, et al.
Published: (2019-03-01)

Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma
by: Virginia Ferraresi, et al.
Published: (2022-05-01)

Treatment complication, pathologic response and survival rate after chemotherapy before surgery in locally advanced cervical cancer
by: Sareh Hosseini, et al.
Published: (2020-02-01)

Evaluation of pretreatment ADC values as predictors of treatment response to neoadjuvant chemotherapy in patients with breast cancer - a multicenter study
by: Alexey Surov, et al.
Published: (2022-12-01)

Neoadjuvant approach in patients with early breast cancer: patient assessment, staging, and planning
by: Isabel T. Rubio, et al.
Published: (2022-03-01)

Neoadjuvant chemotherapy in treatment of cervical cancer: Controversies
by: Mandić Aljoša
Published: (2005-01-01)

Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
by: Jin Sun Lee, et al.
Published: (2020-05-01)

Resultados del tratamiento inductivo en el cáncer de pulmón de células no pequeñas localmente avanzado Results of the inductive treatment of locally advanced non-small cell lung cancer
Published: (2007-09-01)

Hepatoblastoma: Analysis of treatment outcome from a tertiary care center
by: Sanju Cyriac, et al.
Published: (2011-01-01)

Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metanalysis of Oncological Outcomes
by: Raffaello Roesel, et al.
Published: (2023-09-01)

Progress in Multimodal Treatment for Advanced Esophageal Squamous Cell Carcinoma: Results of Multi-Institutional Trials Conducted in Japan
by: Kazuo Koyanagi, et al.
Published: (2020-12-01)